361 related articles for article (PubMed ID: 17970663)
1. The nanoscale in pulmonary delivery. Part 1: deposition, fate, toxicology and effects.
Rogueda PG; Traini D
Expert Opin Drug Deliv; 2007 Nov; 4(6):595-606. PubMed ID: 17970663
[TBL] [Abstract][Full Text] [Related]
2. The nanoscale in pulmonary delivery. Part 2: formulation platforms.
Rogueda PG; Traini D
Expert Opin Drug Deliv; 2007 Nov; 4(6):607-20. PubMed ID: 17970664
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle formulations in pulmonary drug delivery.
Bailey MM; Berkland CJ
Med Res Rev; 2009 Jan; 29(1):196-212. PubMed ID: 18958847
[TBL] [Abstract][Full Text] [Related]
4. Inhaled nanoparticles--a current review.
Yang W; Peters JI; Williams RO
Int J Pharm; 2008 May; 356(1-2):239-47. PubMed ID: 18358652
[TBL] [Abstract][Full Text] [Related]
5. The influence of pulmonary surfactant on nanoparticulate drug delivery systems.
Schleh C; Rothen-Rutishauser B; Kreyling WG
Eur J Pharm Biopharm; 2011 Apr; 77(3):350-2. PubMed ID: 21195761
[TBL] [Abstract][Full Text] [Related]
6. Formation, characterization, and fate of inhaled drug nanoparticles.
Zhang J; Wu L; Chan HK; Watanabe W
Adv Drug Deliv Rev; 2011 May; 63(6):441-55. PubMed ID: 21118707
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticles for drug delivery to the lungs.
Sung JC; Pulliam BL; Edwards DA
Trends Biotechnol; 2007 Dec; 25(12):563-70. PubMed ID: 17997181
[TBL] [Abstract][Full Text] [Related]
8. Clinical perspectives on pulmonary systemic and macromolecular delivery.
Scheuch G; Kohlhaeufl MJ; Brand P; Siekmeier R
Adv Drug Deliv Rev; 2006 Oct; 58(9-10):996-1008. PubMed ID: 16996638
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model.
Beck-Broichsitter M; Gauss J; Packhaeuser CB; Lahnstein K; Schmehl T; Seeger W; Kissel T; Gessler T
Int J Pharm; 2009 Feb; 367(1-2):169-78. PubMed ID: 18848609
[TBL] [Abstract][Full Text] [Related]
10. Immunological and toxicological implications of short-term studies in animals of pharmaceutical aerosol delivery to the lungs: relevance to humans.
Hickey AJ; Garcia-Contreras L
Crit Rev Ther Drug Carrier Syst; 2001; 18(4):387-431. PubMed ID: 11605897
[TBL] [Abstract][Full Text] [Related]
11. Targeted delivery of nanoparticles for the treatment of lung diseases.
Azarmi S; Roa WH; Löbenberg R
Adv Drug Deliv Rev; 2008 May; 60(8):863-75. PubMed ID: 18308418
[TBL] [Abstract][Full Text] [Related]
12. Particle engineering techniques for inhaled biopharmaceuticals.
Shoyele SA; Cawthorne S
Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1009-29. PubMed ID: 17005293
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary drug delivery: medicines for inhalation.
Henning A; Hein S; Schneider M; Bur M; Lehr CM
Handb Exp Pharmacol; 2010; (197):171-92. PubMed ID: 20217530
[TBL] [Abstract][Full Text] [Related]
14. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery.
Sakagami M
Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1030-60. PubMed ID: 17010473
[TBL] [Abstract][Full Text] [Related]
15. Insulin-micro- and nanoparticles for pulmonary delivery.
Klingler C; Müller BW; Steckel H
Int J Pharm; 2009 Jul; 377(1-2):173-9. PubMed ID: 19446621
[TBL] [Abstract][Full Text] [Related]
16. Particle engineering for pulmonary drug delivery.
Chow AH; Tong HH; Chattopadhyay P; Shekunov BY
Pharm Res; 2007 Mar; 24(3):411-37. PubMed ID: 17245651
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticles for direct nose-to-brain delivery of drugs.
Mistry A; Stolnik S; Illum L
Int J Pharm; 2009 Sep; 379(1):146-57. PubMed ID: 19555750
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary administration of therapeutic proteins using an immunoglobulin transport pathway.
Bitonti AJ; Dumont JA
Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1106-18. PubMed ID: 16997417
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting toxicity and efficacy of polymeric nanomedicines.
Igarashi E
Toxicol Appl Pharmacol; 2008 May; 229(1):121-34. PubMed ID: 18355886
[TBL] [Abstract][Full Text] [Related]
20. Nano-salbutamol dry powder inhalation: a new approach for treating broncho-constrictive conditions.
Bhavna ; Ahmad FJ; Mittal G; Jain GK; Malhotra G; Khar RK; Bhatnagar A
Eur J Pharm Biopharm; 2009 Feb; 71(2):282-91. PubMed ID: 18984050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
